Clinical trials
Observational Intellectual Disability trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 6 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 6 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Montpellier | 5 |
| Hospices Civils de Lyon | 4 |
| Central Hospital, Nancy, France | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| University Hospital, Bordeaux | 2 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Nantes University Hospital | 1 |
| University Hospital, Strasbourg, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intellectual Disability | 20 |
| Autism Spectrum Disorder | 3 |
| Rare Diseases | 3 |
| Genetic Diseases, Inborn | 2 |
| Abnormalities, Multiple | 1 |
| Albinism | 1 |
| Anxiety Disorders | 1 |
| Autistic Disorder | 1 |
| Congenital Abnormalities | 1 |
| Down Syndrome | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.